<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikem.org/w/index.php?action=history&amp;feed=atom&amp;title=Pregabalin</id>
	<title>Pregabalin - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikem.org/w/index.php?action=history&amp;feed=atom&amp;title=Pregabalin"/>
	<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Pregabalin&amp;action=history"/>
	<updated>2026-04-16T23:34:22Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.38.2</generator>
	<entry>
		<id>https://wikem.org/w/index.php?title=Pregabalin&amp;diff=128900&amp;oldid=prev</id>
		<title>ClaireLewis: Created page with &quot;==Administration== *Type: GABA analog, analgesic *Dosage Forms: *Routes of Administration: oral *Common Trade Names: Lyrica  ==Adult Dosing== *50-200mg PO TID  ==Pediatric Dos...&quot;</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Pregabalin&amp;diff=128900&amp;oldid=prev"/>
		<updated>2017-03-28T18:31:27Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;==Administration== *Type: GABA analog, analgesic *Dosage Forms: *Routes of Administration: oral *Common Trade Names: Lyrica  ==Adult Dosing== *50-200mg PO TID  ==Pediatric Dos...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;==Administration==&lt;br /&gt;
*Type: GABA analog, analgesic&lt;br /&gt;
*Dosage Forms:&lt;br /&gt;
*Routes of Administration: oral&lt;br /&gt;
*Common Trade Names: Lyrica&lt;br /&gt;
&lt;br /&gt;
==Adult Dosing==&lt;br /&gt;
*50-200mg PO TID&lt;br /&gt;
&lt;br /&gt;
==Pediatric Dosing==&lt;br /&gt;
''Safety/efficacy not established''&lt;br /&gt;
&lt;br /&gt;
==Special Populations==&lt;br /&gt;
*[[Drug pregnancy categories|Pregnancy Rating]]: C (though fetal risk has been demonstrated)&lt;br /&gt;
*Lactation risk: Infant risk has been demonstrated&lt;br /&gt;
*Renal dosing: reduce dose per manufacturer/FDA guidelines&lt;br /&gt;
*Hepatic dosing:&lt;br /&gt;
&lt;br /&gt;
==Contraindications==&lt;br /&gt;
*Allergy to class/drug&lt;br /&gt;
&lt;br /&gt;
==Adverse Reactions==&lt;br /&gt;
===Serious===&lt;br /&gt;
*Angioedema, hypersensitivity reaction&lt;br /&gt;
*Jaundice&lt;br /&gt;
*Elevated creatine kinase level&lt;br /&gt;
*Suicidal thoughts&lt;br /&gt;
&lt;br /&gt;
===Common===&lt;br /&gt;
*Constipation, xerostomia, weight gain&lt;br /&gt;
*Peripheral edema&lt;br /&gt;
*Dizziness, ataxia, somnolence, blurred vision, headache&lt;br /&gt;
*Nasopharyngitis&lt;br /&gt;
*Disturbance in thinking, euphoria&lt;br /&gt;
&lt;br /&gt;
==Pharmacology==&lt;br /&gt;
*Half-life: 6.3h&lt;br /&gt;
*Metabolism: &lt;br /&gt;
*Excretion: Mostly renal&lt;br /&gt;
&lt;br /&gt;
==Mechanism of Action==&lt;br /&gt;
*GABA-analog, exact mechanism of analgesic effect poorly understood&lt;br /&gt;
&lt;br /&gt;
==Comments==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Pharmacology]]&lt;/div&gt;</summary>
		<author><name>ClaireLewis</name></author>
	</entry>
</feed>